Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREATMENT OF THE RECESSIVE NONBULLOUS CONGENITAL ICHTHYOSIS BY THE EPIGALLOCATECHINE CUTANEOUS
NCT01222000Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Oct 2010
- Primary completion
- Mar 2012
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epigallocatechin gallate in lamellar ichthyosis (LI), sponsored by Centre Hospitalier Universitaire de Nice. Started Oct 2010; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
lamellar ichthyosis (LI)
Beyond the preview
Go deeper on NCT01222000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01222000.